New developments in anti‐sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo ?-Reference-Cited by-同舟云学术

New developments in anti‐sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo ?

Published:2016-09-08 Issue:1 Volume:175 Page:24-30
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Oder Esther¹,Safo Martin K.²,Abdulmalik Osheiza³,Kato Gregory J.⁴^ORCID

Affiliation:

1. School of Pharmacy University of Pittsburgh Pittsburgh PA USA

2. Department of Medicinal Chemistry Institute for Structural Biology Drug Discovery and Development School of Pharmacy Virginia Commonwealth University Richmond VA USA

3. Division of Hematology The Children's Hospital of Philadelphia PhiladelphiaPA USA

4. Department of Medicine Division of Hematology‐Oncology and the Heart, Lung, Blood and Vascular Medicine Institute University of Pittsburgh School of Medicine Pittsburgh PA USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.14264

Reference58 articles.

1. Glycosylation of hemoglobin S by reducing sugars and its effect on gelation

2. 5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells

3. Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin